Shane Maltbie - Feb 4, 2025 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role: Chief Financial Officer
Signature: /s/ Paul Bavier, Attorney-in-Fact for Shane Maltbie
Stock symbol: HLVX
Transactions as of: Feb 4, 2025
Transactions value $: -$15,117
Form type: 4
Date filed: 2/12/2025, 04:05 PM
Previous filing: Feb 12, 2024
Next filing: Sep 17, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HLVX	Common Stock	Sale	-$7.46K	-3.95K	-4.48%	$1.89	84.2K	Feb 4, 2025	Direct	F1
transaction	HLVX	Common Stock	Sale	-$7.66K	-4.35K	-5.16%	$1.76	79.9K	Feb 11, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units ("RSUs"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices between $1.7508 and $1.7745. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units ("RSUs"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices between $1.7508 and $1.7745. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.